Systemtherapie 1. Linie (metastasierte Erkrankung / Hämatologie)
Phase I trial to assess the cardiac safety of treosulfan-based conditioning therapy in subjects with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation
Phase I trial to assess the cardiac safety of treosulfan-based conditioning therapy in subjects with AML or MDS undergoing allogeneic hematopoietic stem cell transplantation